CSF spectrophotometry for bilirubin – why and how?

References

• Rinkel G. J. E., van Gijn J., Wijdicks E. F. M. Subarachnoid haemorrhage without detectable aneurysm: a review of the causes. Stroke 1993; 24: 1403–9
   PubMed Web of Science ®Google Scholar
• Edlow J. A., Caplan L. R. Avoiding pitfalls in the diagnosis of subarachnoid haemorrhage. N Engl J Med 2000; 342: 29–36
   PubMed Web of Science ®Google Scholar
• Brisman J. L., Song J. K., Newell D. W. Cerebral aneurysms. N Engl J Med 2006; 355: 928–39
   PubMed Web of Science ®Google Scholar
• Boesiger B. M., Shiber J. R. Subarachnoid haemorrhage diagnosed by computed |tomography and lumbar puncture: are fifth generation CT scanners better at identifying subarachnoid haemorrhage?. J Emerg Med 2005; 29: 23–7
   PubMed Web of Science ®Google Scholar
• Schievink W. I., Wijdicks E. F. M. Pretruncal nonaneurysmal subarachnoid haemorrhage. Stroke 1997; 28: 2572
   PubMed Web of Science ®Google Scholar
• Van der Wee N., Rinkel G. J. E., Hasan D., van Gijn J. Detection of subarachnoid haemorrhage on early CT: is lumbar puncture still needed after a negative scan?. J Neurol Neurosurg Psychiatry 1995; 58: 357–9
   PubMed Web of Science ®Google Scholar
• Gunawardena H., Beetham R., Scolding N., Lhatoo S. D. Is cerebrospinal fluid spectrophotometry useful in CT scan‐negative patients?. Eur Neurol 2004; 52: 226–9
   PubMedGoogle Scholar
• Vindlacheruvu R. R., Mendelow A. D., Mitchell P. Risk‐benefit analysis of the treatment of unruptured intracranial aneurysms. J Neurol Neurosurg Psychiatry 2005; 76: 234–9
   PubMed Web of Science ®Google Scholar
• Marton K., Vendor M. The lumbar puncture: patterns of use in clinical practice. Med Decis Making 1981; 1: 331–4
   PubMedGoogle Scholar
• Tourtellotte W. W., Somers J. F., Parker J. A., Itabashi H. H., Dejong R. N. A study on traumatic lumbar punctures. Neurology 1958; 8: 129–34
   PubMedGoogle Scholar
• Buruma O. J. S., Janson H. L. F., den Bergh F. A. J. T. M., Bots G. T. H. A. M. Bloodstained cerebrospinal fluid: traumatic puncture or haemorrhage?. J Neurol Neurosurg Psychiatry 1981; 44: 144–7
   PubMed Web of Science ®Google Scholar
• Friedman J. A., Wijdicks E. J. M. 10 most commonly asked questions about subarachnoid haemorrhage. Neurologist 2002; 8: 271–6
   PubMedGoogle Scholar
• Gerber C. J., Crawford P., Mendelow A. D., Gholkar A., Sengupta R. P. Lumbar puncture should not be delayed in subarachnoid haemorrhage. Br Med J 1998; 317: 148
   PubMedGoogle Scholar
• Kjellin K. G., Söderström C. E. Diagnostic significance of CSF spectrophotometry in cerebrovascular disease. J Neurol Sci 1974; 23: 359–69
   PubMed Web of Science ®Google Scholar
• Marden N. A., Thomas P. H., Stansbie D. Is the naked eye as sensitive as the spectrophotometer for detecting xanthochromia in cerebrospinal fluid?. Proceedings of the National Meeting 2001, London, S. M Martin. Association of Clinical Biochemists, London 2001; 53
   Google Scholar
• Cruickshank A., Beetham R., Holbrook I., Watson I., Wenham P., Keir G., et al. Spectrophotometry of cerebrospinal fluid in suspected subarachnoid haemorrhage. Br Med J 2005; 330: 138
   PubMedGoogle Scholar
• Petzold A., Keir G., Sharpe T. L. Why human colour vision cannot reliably detect cerebrospinal fluid xanthochromia. Stroke 2005; 36: 1295–7
   PubMed Web of Science ®Google Scholar
• Linn F. H. H., Voorbij H. A. M., Rinkel G. J. E., Algra A., van Gijn J. Visual inspection versus spectrophotometry in detecting bilirubin in cerebrospinal fluid. J Neurol Neurosurg Psychiatry 2005; 76: 1452–4
   PubMed Web of Science ®Google Scholar
• Perry J. J., Sivilotti M. L. A., Stiell I. G., Wells G. A., Raymond J., Mortensen M., et al. Should spectrophotometry be used to identify xanthochromia in the cerebrospinal fluid of alert patients suspected of having subarchnoid haemorrhage?. Stroke 2006; 37: 2467–72
   PubMedGoogle Scholar
• Beetham R., Lhatoo S. Should spectrophotometry be used to identify xanthochromia in the cerebrospinal fluid of alert patients suspected of having subarchnoid haemorrhage?. Stroke 2007; 38: e86
   Google Scholar
• Sandhaus L. M. CSF spectrophotometry in questionable SAH, A continental divide. Neurocritical Care 2006; 4: 101–2
   PubMedGoogle Scholar
• Beetham R. CSF bilirubin‐spectrophotometry or direct measurement. Ann Clin Biochem 2007; 44: 99–100
   PubMedGoogle Scholar
• Watson I. D., Beetham R., Holbrook I. B., Fahie‐Wilson M. N., O'Connell D. What is the role of cerebrospinal fluid ferritin in the diagnosis of subarachnoid haemorrhage in computed tomography‐negative patients?. Ann Clin Biochem 2008; 45: 89–92
   Google Scholar
• Barrows L. J., Hunter F. T., Banker B. Q. The nature and clinical significance of pigments in the cerebrospinal fluid. Brain 1955; 78: 59–80
   PubMedGoogle Scholar
• Söderström C. E. Diagnostic significance of CSF spectrophotometry and computer tomography in cerebrovascular disease. A comparative study in 231 cases. Stroke 1977; 8: 606–12
   PubMedGoogle Scholar
• Beetham R. The examination of cerebrospinal fluid in CT scan negative suspected subarachnoid haemorrhage. CPD Bull Clin Biochem 2006; 7: 25–31
   Google Scholar
• UK National External Quality Assessment Scheme for Immunochemistry Working Group. National guidelines for analysis of cerebrospinal fluid for bilirubin in suspected subarachnoid haemorrhage. Ann Clin Biochem 2003; 40: 481–8
   PubMed Web of Science ®Google Scholar
• Cruickshank A., Auld P., Beetham R., Burrows G., Egner W., Holbrook I., et al. Revised national guidelines for analysis of cerebrospinal fluid for bilirubin in suspected subarachnoid haemorrhage. Ann Clin Biochem 2008; 45: 238–44
   PubMed Web of Science ®Google Scholar
• Chalmers A. H. Cerebrospinal fluid xanthochromia testing simplified. Clin Chem 2001; 47: 147–8
   PubMed Web of Science ®Google Scholar
• UK National External Quality Assessment Scheme for Immunochemistry: CSF Proteins and Immunochemistry. Available at: www.immqas.org.uk
   Google Scholar